| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/24/2003 | WO2003032894A2 Method of monitoring neuroprotective treatment |
| 04/24/2003 | WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | WO2003032813A2 Methods for the treatment of carcinoma |
| 04/24/2003 | WO2003032810A2 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | WO2003006614A3 UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 04/24/2003 | WO2003004699A3 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 04/24/2003 | WO2003002975A3 Biophotonic sensors and methods of use thereof |
| 04/24/2003 | WO2003001208A3 Assay and process for the detection of hpv antibodies |
| 04/24/2003 | WO2002099387A3 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/24/2003 | WO2002095419A3 Peptide analysis using a solid support |
| 04/24/2003 | WO2002095412A3 Peptide fragmentation |
| 04/24/2003 | WO2002094777A3 Methods of detecting protein arginine methyltransferase, and uses related thereto |
| 04/24/2003 | WO2002093162A3 Individualization of therapy with antibiotic agents |
| 04/24/2003 | WO2002088706A3 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 04/24/2003 | WO2002088343A3 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |
| 04/24/2003 | WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 04/24/2003 | WO2002085295A3 Methods and compositions for the modulation of biofilm formation |
| 04/24/2003 | WO2002079429A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002072624A3 Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| 04/24/2003 | WO2002071072A3 Method and device for processing proteins in gels |
| 04/24/2003 | WO2002070011A3 Treatment of ppar mediated diseases |
| 04/24/2003 | WO2002068695A3 Quantitative immunohistochemistry (qihc) |
| 04/24/2003 | WO2002066981A3 Monitoring soluble endothelial protein c receptor levels in anticoagulant therapy |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002065129A3 Epitopic sequences for diagnosing infection by chlamydia trachomatis |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002063000A9 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 04/24/2003 | WO2002059596A3 Method and apparatus for measurement of the sulfate concentration in air samples |
| 04/24/2003 | WO2002057483A3 Method of identifying modulators of nogo-functions |
| 04/24/2003 | WO2002055552A3 Soluble cyclic analogues of beta amyloid peptide |
| 04/24/2003 | WO2002054086A9 Method of compensating for drift in gas sensing equipment |
| 04/24/2003 | WO2002051537A3 Optical bio-discs and methods relating thereto |
| 04/24/2003 | WO2002050541A3 Devices for conducting binding assays |
| 04/24/2003 | WO2002049576A9 Fab i and inhibition of apicomplexan parasites |
| 04/24/2003 | WO2002048701A3 Nanosensors |
| 04/24/2003 | WO2002048392A3 Screening method for inhibitors of pyruvate orthophosphate dikinase |
| 04/24/2003 | WO2002046746A3 Method for detection of vitamin d metabolites |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002046234A8 Cocaine haptens |
| 04/24/2003 | WO2002040966A9 Compression test method and apparatus for determining granule strength |
| 04/24/2003 | WO2002039126A8 Stable, reliable capacitive oil deterioration and level sensor |
| 04/24/2003 | WO2002031498A3 Protecting therapeutic compositions from host-mediated inactivation |
| 04/24/2003 | WO2002030980A3 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 04/24/2003 | WO2002014872A3 Sequence data preparation method and apparatus |
| 04/24/2003 | WO2002014836A3 Apparatus and methods for measuring extensional rheological properties of a material |
| 04/24/2003 | WO2002014554A3 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2001083821A3 Polynucleotide probes for detection and quantitation of candida species |
| 04/24/2003 | WO2001081919A3 Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | US20030079241 Isolation of precancerous tissue; obtain mammary gland tissue from cancer prone rodent, implant cells into nontrangenic rodent, detect propagation of cells, generate clonal series from propagating cells |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030079236 Polymorphisms associated with internalizing disorders |
| 04/24/2003 | US20030078761 Tool for in vitro-in vivo correlation |
| 04/24/2003 | US20030078760 Population pharmacokinetic modeling and analysis (PDx-POP™) |
| 04/24/2003 | US20030078759 Method and apparatus for computer modeling a joint |
| 04/24/2003 | US20030078738 Method and apparatus for detecting outliers in biological/parmaceutical screening experiments |
| 04/24/2003 | US20030078736 Methods for generating differential profiles by combining data obtained in separate measurements |
| 04/24/2003 | US20030078518 Method of treating the skin of a subject |
| 04/24/2003 | US20030078517 In vivo delivery methods and compositions |
| 04/24/2003 | US20030078511 Method and system of diagnosing intrapulmonary infection using an electronic nose |
| 04/24/2003 | US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078396 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 04/24/2003 | US20030078389 Gamma-heregulin |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078382 Human Ect2 and methods of use |
| 04/24/2003 | US20030078381 Composition for use in the detection and treatment of cancer |
| 04/24/2003 | US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078314 Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays |
| 04/24/2003 | US20030078293 Administering etodolac for therapy of prostate cancer in a mammals |
| 04/24/2003 | US20030078246 Combinations for the treatment of inflammatory disorders |
| 04/24/2003 | US20030078237 Treatment of a central nervous system disorders |
| 04/24/2003 | US20030078224 An isolated polynucleotide for treating prostate and non-prostate tumors in a gene therapy |
| 04/24/2003 | US20030078222 Human receptor tyrosine kinase |
| 04/24/2003 | US20030078202 Receptor derived peptides involved in modulation of response to ligand binding |
| 04/24/2003 | US20030078188 Altering the conformation of the cytoplasmic kinase domain; drug screening; combinatorial chemistry |
| 04/24/2003 | US20030077842 Recovering preferential particles from sample; obtain sample contain surface bound ligand bound to preferential particle, elute particle, dissociate particle from ligand, recover particle from fluid |
| 04/24/2003 | US20030077841 Therapeutic potential of immunoglobulin preparations |
| 04/24/2003 | US20030077840 Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy |
| 04/24/2003 | US20030077839 Method and apparatus for recovering biomolecules |
| 04/24/2003 | US20030077838 Analysis of sample containing preferential particulate matter; obtain sample, insert into container, analyze sample |
| 04/24/2003 | US20030077834 Measurement of aldehyde present in a polymer; obtain sample, extract gaseous aldehyde, react with chemical intermediates, determine aldehyde concentration |
| 04/24/2003 | US20030077833 Diagnositc methods for determining susceptibility to convulsive conditions |
| 04/24/2003 | US20030077832 Methods and compositions for detection of breast cancer |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
| 04/24/2003 | US20030077817 Microfermentor device and cell based screening method |
| 04/24/2003 | US20030077792 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077791 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077790 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077788 Secreted and transmembrane polypeptides and nucleic acids encoding the same |